CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	Total	Common Stock	Capital in Excess of Par Value	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance at Dec. 31, 2024	$ 4,372	$ 1	$ 811	$ (1,131)	$ (239)	$ 4,930
Beginning balance (in shares) at Dec. 31, 2024		123,119,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(166)					(166)
Other comprehensive (loss) income	5				5
Common stock repurchase (in shares)		(1,766,000)
Common stock repurchase	(107)			(107)
Stock-based compensation (in shares)		5,000.000
Stock-based compensation	22		22
CARES Act warrants exercised		810,000
Stock issued under stock plans (in shares)		717,000
Stock issued under stock plans	11		11
Ending balance at Mar. 31, 2025	4,137	$ 1	844	(1,238)	(234)	4,764
Ending balance (in shares) at Mar. 31, 2025		122,885,000
Beginning balance at Dec. 31, 2024	4,372	$ 1	811	(1,131)	(239)	4,930
Beginning balance (in shares) at Dec. 31, 2024		123,119,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	6
Other comprehensive (loss) income	$ 11
Common stock repurchase (in shares)	(10,500,000)
Common stock repurchase	$ (535)
Ending balance at Jun. 30, 2025	3,942	$ 1	899	(1,666)	(228)	4,936
Ending balance (in shares) at Jun. 30, 2025		115,276,000
Beginning balance at Mar. 31, 2025	4,137	$ 1	844	(1,238)	(234)	4,764
Beginning balance (in shares) at Mar. 31, 2025		122,885,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	172					172
Other comprehensive (loss) income	6				6
Common stock repurchase (in shares)		(8,721,000)
Common stock repurchase	(428)			(428)
Stock-based compensation (in shares)		9,000.000
Stock-based compensation	17		17
Stock issued for employee stock purchase plan (in shares)		1,023,000.000
Stock issued for employee stock purchase plan	39		39
Stock issued under stock plans (in shares)		80,000.000
Stock issued under stock plans	(1)		(1)
Ending balance at Jun. 30, 2025	3,942	$ 1	899	(1,666)	(228)	4,936
Ending balance (in shares) at Jun. 30, 2025		115,276,000
Beginning balance at Dec. 31, 2025	$ 4,118	$ 1	961	(1,701)	(173)	5,030
Beginning balance (in shares) at Dec. 31, 2025	115,530,889	115,531,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	$ (193)					(193)
Other comprehensive (loss) income	(3)				(3)
Common stock repurchase (in shares)		(4,687,000)
Common stock repurchase	(203)			(203)
Stock-based compensation	24		24
Stock issued under stock plans (in shares)		516,000
Stock issued under stock plans	(12)		(12)
Ending balance at Mar. 31, 2026	3,731	$ 1	973	(1,904)	(176)	4,837
Ending balance (in shares) at Mar. 31, 2026		111,360,000
Beginning balance at Dec. 31, 2025	$ 4,118	$ 1	961	(1,701)	(173)	5,030
Beginning balance (in shares) at Dec. 31, 2025	115,530,889	115,531,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	$ (269)
Other comprehensive (loss) income	$ (2)
Common stock repurchase (in shares)	(5,900,000)
Common stock repurchase	$ (250)
Ending balance at Jun. 30, 2026	$ 3,670	$ 1	1,034	(1,951)	(175)	4,761
Ending balance (in shares) at Jun. 30, 2026	111,566,970	111,567,000
Beginning balance at Mar. 31, 2026	$ 3,731	$ 1	973	(1,904)	(176)	4,837
Beginning balance (in shares) at Mar. 31, 2026		111,360,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income (Loss)	(76)					(76)
Other comprehensive (loss) income	1				1
Common stock repurchase (in shares)		(1,249,000)
Common stock repurchase	(47)			(47)
Stock-based compensation (in shares)		33,000.000
Stock-based compensation	20		20
Stock issued for employee stock purchase plan (in shares)		1,310,000
Stock issued for employee stock purchase plan	43		43
Stock issued under stock plans (in shares)		113,000
Stock issued under stock plans	(2)		(2)
Ending balance at Jun. 30, 2026	$ 3,670	$ 1	$ 1,034	$ (1,951)	$ (175)	$ 4,761
Ending balance (in shares) at Jun. 30, 2026	111,566,970	111,567,000